Regulated Information

Official regulatory filings and disclosures in compliance with applicable securities regulations.

Filter by

Filter By Year (Documentation)
Document Type

Explore More

Financial Press Releases Right-open-mini Right-open-mini Investor Newsletters Right-open-mini Right-open-mini Financial Information Right-open-mini Right-open-mini Governance Right-open-mini Right-open-mini

A New Chapter

Founded in 2012 to realize the potential of gene therapy, GenSight Biologics has grown into a clinical-stage company advancing multiple programs. In 2024, under a new management team, the company entered a new phase and is now accelerating its clinical and regulatory activities.

Explore investors’ hub

Join Our Newsletter Community

"*" indicates required fields

Consent*

GenSight Biologics S.A.
74 rue du Faubourg Saint-Antoine
75012 Paris
France

Our Story

Driven by science, focused on patients, and innovating for vision.

Pipeline

Building a portfolio of innovative therapies for diseases with significant unmet need.

Investor Hub

Follow our progress as we advance programs designed to have meaningful patient impact.

Contact

Connect with our team for partnership opportunities, investor inquiries, or general questions.

Copyright © 2026 GenSight Biologics.
All rights reserved.
Legal Notice | Privacy Policy | Cookies Policy | Terms of Use

Site Design by RainCastle Communications.